115 related articles for article (PubMed ID: 37293016)
41. [Molecular and cellular characterization ion of IKAP protein and the Elongator complex. Implications for familial dysautonomia].
Close P; Creppe C; Cornez I; Chariot A
Bull Mem Acad R Med Belg; 2007; 162(5-6):315-22. PubMed ID: 18405001
[TBL] [Abstract][Full Text] [Related]
42. A novel ELP1 mutation impairs the function of the Elongator complex and causes a severe neurodevelopmental phenotype.
Kojic M; Abbassi NEH; Lin TY; Jones A; Wakeling EL; Clement E; Nakou V; Singleton M; Dobosz D; Kaliakatsos M; Glatt S; Wainwright BJ
J Hum Genet; 2023 Jul; 68(7):445-453. PubMed ID: 36864284
[TBL] [Abstract][Full Text] [Related]
43. Tocotrienol Treatment in Familial Dysautonomia: Open-Label Pilot Study.
Cheishvili D; Maayan C; Holzer N; Tsenter J; Lax E; Petropoulos S; Razin A
J Mol Neurosci; 2016 Jul; 59(3):382-91. PubMed ID: 27129499
[TBL] [Abstract][Full Text] [Related]
44. Cardiac glycosides correct aberrant splicing of IKBKAP-encoded mRNA in familial dysautonomia derived cells by suppressing expression of SRSF3.
Liu B; Anderson SL; Qiu J; Rubin BY
FEBS J; 2013 Aug; 280(15):3632-46. PubMed ID: 23711097
[TBL] [Abstract][Full Text] [Related]
45. Phosphatidylserine increases IKBKAP levels in a humanized knock-in IKBKAP mouse model.
Bochner R; Ziv Y; Zeevi D; Donyo M; Abraham L; Ashery-Padan R; Ast G
Hum Mol Genet; 2013 Jul; 22(14):2785-94. PubMed ID: 23515154
[TBL] [Abstract][Full Text] [Related]
46. Loss-of-function of IKAP/ELP1: could neuronal migration defect underlie familial dysautonomia?
Naumanen T; Johansen LD; Coffey ET; Kallunki T
Cell Adh Migr; 2008; 2(4):236-9. PubMed ID: 19262150
[TBL] [Abstract][Full Text] [Related]
47. Olfactory stem cells, a new cellular model for studying molecular mechanisms underlying familial dysautonomia.
Boone N; Loriod B; Bergon A; Sbai O; Formisano-Tréziny C; Gabert J; Khrestchatisky M; Nguyen C; Féron F; Axelrod FB; Ibrahim EC
PLoS One; 2010 Dec; 5(12):e15590. PubMed ID: 21187979
[TBL] [Abstract][Full Text] [Related]
48. A humanized IKBKAP transgenic mouse models a tissue-specific human splicing defect.
Hims MM; Shetty RS; Pickel J; Mull J; Leyne M; Liu L; Gusella JF; Slaugenhaupt SA
Genomics; 2007 Sep; 90(3):389-96. PubMed ID: 17644305
[TBL] [Abstract][Full Text] [Related]
49.
Rubin BY; Anderson SL
Appl Clin Genet; 2017; 10():95-103. PubMed ID: 29290691
[TBL] [Abstract][Full Text] [Related]
50. Selective retinal ganglion cell loss in familial dysautonomia.
Mendoza-Santiesteban CE; Hedges Iii TR; Norcliffe-Kaufmann L; Axelrod F; Kaufmann H
J Neurol; 2014 Apr; 261(4):702-9. PubMed ID: 24487827
[TBL] [Abstract][Full Text] [Related]
51. Of splice and men: what does the distribution of IKAP mRNA in the rat tell us about the pathogenesis of familial dysautonomia?
Mezey E; Parmalee A; Szalayova I; Gill SP; Cuajungco MP; Leyne M; Slaugenhaupt SA; Brownstein MJ
Brain Res; 2003 Sep; 983(1-2):209-14. PubMed ID: 12914982
[TBL] [Abstract][Full Text] [Related]
52. Uncommon side effects of common drugs in patients with familial dysautonomia.
Perl L; Hakimian D; Maayan C; Rekhtman D; Fried E; Salmon-Divon M; Sapozhnikov DM; Cheishvili D
Pharmacoepidemiol Drug Saf; 2022 Feb; 31(2):128-140. PubMed ID: 34245206
[TBL] [Abstract][Full Text] [Related]
53. Therapeutic potential and mechanism of kinetin as a treatment for the human splicing disease familial dysautonomia.
Hims MM; Ibrahim EC; Leyne M; Mull J; Liu L; Lazaro C; Shetty RS; Gill S; Gusella JF; Reed R; Slaugenhaupt SA
J Mol Med (Berl); 2007 Feb; 85(2):149-61. PubMed ID: 17206408
[TBL] [Abstract][Full Text] [Related]
54. Familial dysautonomia.
Slaugenhaupt SA; Gusella JF
Curr Opin Genet Dev; 2002 Jun; 12(3):307-11. PubMed ID: 12076674
[TBL] [Abstract][Full Text] [Related]
55. IKAP deficiency in an FD mouse model and in oligodendrocyte precursor cells results in downregulation of genes involved in oligodendrocyte differentiation and myelin formation.
Cheishvili D; Dietrich P; Maayan C; Even A; Weil M; Dragatsis I; Razin A
PLoS One; 2014; 9(4):e94612. PubMed ID: 24760006
[TBL] [Abstract][Full Text] [Related]
56. Genome-wide analysis of familial dysautonomia and kinetin target genes with patient olfactory ecto-mesenchymal stem cells.
Boone N; Bergon A; Loriod B; Devèze A; Nguyen C; Axelrod FB; Ibrahim EC
Hum Mutat; 2012 Mar; 33(3):530-40. PubMed ID: 22190446
[TBL] [Abstract][Full Text] [Related]
57. Weak definition of IKBKAP exon 20 leads to aberrant splicing in familial dysautonomia.
Ibrahim EC; Hims MM; Shomron N; Burge CB; Slaugenhaupt SA; Reed R
Hum Mutat; 2007 Jan; 28(1):41-53. PubMed ID: 16964593
[TBL] [Abstract][Full Text] [Related]
58. Specific correction of a splice defect in brain by nutritional supplementation.
Shetty RS; Gallagher CS; Chen YT; Hims MM; Mull J; Leyne M; Pickel J; Kwok D; Slaugenhaupt SA
Hum Mol Genet; 2011 Nov; 20(21):4093-101. PubMed ID: 21821670
[TBL] [Abstract][Full Text] [Related]
59. Mouse γ-Synuclein Promoter-Mediated Gene Expression and Editing in Mammalian Retinal Ganglion Cells.
Wang Q; Zhuang P; Huang H; Li L; Liu L; Webber HC; Dalal R; Siew L; Fligor CM; Chang KC; Nahmou M; Kreymerman A; Sun Y; Meyer JS; Goldberg JL; Hu Y
J Neurosci; 2020 May; 40(20):3896-3914. PubMed ID: 32300046
[TBL] [Abstract][Full Text] [Related]
60. Loss of Elp1 perturbs histone H2A.Z and the Notch signaling pathway.
Cameron B; Lehrmann E; Chih T; Walters J; Buksch R; Snyder S; Goffena J; Lefcort F; Becker KG; George L
Biol Open; 2021 Sep; 10(9):. PubMed ID: 34590699
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
